Cargando…
In Vivo Dopamine Neuron Imaging-Based Small Molecule Screen Identifies Novel Neuroprotective Compounds and Targets
Parkinson’s disease (PD) is the second most common neurodegenerative disorder with prominent dopamine (DA) neuron degeneration. PD affects millions of people worldwide, but currently available therapies are limited to temporary relief of symptoms. As an effort to discover disease-modifying therapeut...
Autores principales: | Kim, Gha-hyun J., Mo, Han, Liu, Harrison, Okorie, Meri, Chen, Steven, Zheng, Jiashun, Li, Hao, Arkin, Michelle, Huang, Bo, Guo, Su |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971663/ https://www.ncbi.nlm.nih.gov/pubmed/35370735 http://dx.doi.org/10.3389/fphar.2022.837756 |
Ejemplares similares
-
A zebrafish screen reveals Renin-angiotensin system inhibitors as neuroprotective via mitochondrial restoration in dopamine neurons
por: Kim, Gha-Hyun J, et al.
Publicado: (2021) -
Screening of a Small Molecule Compound Library Identifies Toosendanin as an Inhibitor Against Bunyavirus and SARS-CoV-2
por: Li, Shufen, et al.
Publicado: (2021) -
Neuroprotective Potential of a Small Molecule RET Agonist in Cultured Dopamine Neurons and Hemiparkinsonian Rats
por: Renko, Juho-Matti, et al.
Publicado: (2021) -
Histone Deacetylases Inhibitors in Neurodegenerative Diseases, Neuroprotection and Neuronal Differentiation
por: Shukla, Surabhi, et al.
Publicado: (2020) -
theLiTE™: A Screening Platform to Identify Compounds that Reinforce Tight Junctions
por: Gomes, Teresa Lopes, et al.
Publicado: (2022)